Susquehanna Fundamental Investments’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	$66.4K	Sell	54,422 -2,323	-4%	-$2.83K	﹤0.01%	909
2024 Q1	$124K	Buy	+56,745	New	+$124K	0.01%	645
2021 Q3	–	Sell	-39,463	Closed	-$250K	–	1729
2021 Q2	$250K	Buy	+39,463	New	+$250K	﹤0.01%	1421